University of Basel
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.unibas.ch
Clinical Trials
60
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
- Conditions
- Driving Under the Influence of Cannabis
- Interventions
- Drug: Participants will prepare their cannabis product ad libitum and inhale the prepared product as usual for a maximum of 15 minutes.
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- University of Basel
- Target Recruit Count
- 120
- Registration Number
- NCT06975020
Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State
- Conditions
- Minimally Conscious State
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Basel
- Target Recruit Count
- 26
- Registration Number
- NCT06931665
Testing the Implementation of a Toolbox to Optimize Data Collection and Data Quality of the National Medical Quality Indicators in Long-term Care Facilities: a Pilot Study. (NIP-Q-UPGRADE Subaim 1.8)
- Conditions
- Toolbox to Optimize Data Quality of the National MQIs
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- University of Basel
- Target Recruit Count
- 30
- Registration Number
- NCT06848725
- Locations
- 🇨🇭
Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Manno, Switzerland., Manno, TI, Switzerland
🇨🇭Institut für Pflegewissenschaft - Nursing Science (INS), University of Basel, Basel, Switzerland
🇨🇭La Source School of Nursing, HES-SO University of Applied Sciences and Arts of Western Switzerland, Lausanne, Switzerland, Lausanne, Switzerland
Cross-over Study on the Influence of Fampridine on Working Memory in Mild Depression
- Conditions
- Working MemoryMild Depression
- Interventions
- Other: Placebo
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Basel
- Target Recruit Count
- 38
- Registration Number
- NCT06751784
- Locations
- 🇨🇭
University of Basel, Reserach Cluster Molecular and Cognitive Neurosciences, Basel, BS, Switzerland
Sustainable Improvement of INTERprofessional Care for Better Resident Outcomes
- Conditions
- Unplanned Hospitalizations
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Basel
- Target Recruit Count
- 40
- Registration Number
- NCT06473051
- Locations
- 🇨🇭
Institute of Nursing Science, Basel, Switzerland
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
News
CRISPR Screen Reveals Key to Enhancing RNA Drug Efficacy Through Endosomal Transport Modulation
Researchers at University of Basel and Roche used CRISPR/Cas9 screening to identify genes that significantly influence antisense oligonucleotide (ASO) activity, revealing that intracellular transport speed is a critical determinant of therapeutic efficacy.
Swissmedic and Swissethics Release New Guidelines for Decentralized Clinical Trials
Swiss regulatory authorities Swissmedic and Swissethics have jointly issued updated position paper on decentralized clinical trials, marking a significant step in modernizing clinical research frameworks.
Novel Liquid Biopsy System Shows Promise in Preventing Cancer Metastasis
University of Basel researchers demonstrate Angle's Parsortix system can capture over 99% of circulating tumor cell clusters from blood samples, enabling breakthrough metastasis prevention research.